DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Sciences - Boston, June 23-27

About DIA 2013 DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Sciences is the largest multidisciplinary event that brings together a global network of professionals to foster innovation that will lead to the development of safe and effective medical products and therapies to patients.

DIA 2013 49th Annual Meeting will:

• Provide a global unbiased platform to raise the level of discussion to facilitate innovation that will change the future of health care
• Provide comprehensive coverage of the full development and life cycle management process for all health care products
• Offer a holistic and integrated approach to the development and life cycle management of regulated health care products

To that end, DIA 2013 49th Annual Meeting provides the best opportunity to meet with people from around the world, share your views and knowledge, network, and build new relationships.

---

“A lot is being done to try to advance clinical development to become more efficient, to become more effective, and that the DIA provides an opportunity to share those kinds of ideas.” - Jeffrey McMullen, President and CEO, PharmaNet/i3

“Well, DIA really prides itself on providing a neutral forum. And that aspect of neutrality not only means that our attendees can have more confidence in the content, but it also means we have a lot more diversity of stakeholders presenting.” - Craig Lipset, DIA 2012 Program Chair

“It’s definitely one of the leading meetings that we attend.” - Josef von Rickenbach, Chairman and CEO, PAREXEL International

---

DIA’s Annual Meeting brings together all the stakeholders to enhance the health and well-being of patients.